{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:05:00Z","timestamp":1762999500396,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijpharm.2019.118656","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:30:23Z","timestamp":1567769423000},"page":"118656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Anti-counterfeiting DNA molecular tagging of pharmaceutical excipients: An evaluation of lactose containing tablets"],"prefix":"10.1016","volume":"571","author":[{"given":"Mohamad Jamal","family":"Altamimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna C.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahuti","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Royall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2019.118656_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2018.10.061","article-title":"Variability in the a and beta anomer content of commercially available lactose","volume":"555","author":"Altamimi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.118656_b0010","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1002\/adfm.201400298","article-title":"A new anti-counterfeiting feature relying on invisible luminescent full color images printed with lanthanide-based inks","volume":"24","author":"Andres","year":"2014","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpharm.2019.118656_b0015","unstructured":"Applied DNA Sciences, 2019. https:\/\/adnas.com\/security-and-asset-marking-crime-prevention\/ (accessed 11.03.19)."},{"key":"10.1016\/j.ijpharm.2019.118656_b0020","unstructured":"Bar-Or, Y.A., Scheibe, P.O., Plaxco, K.W., Thomas, A.J., 2006. Method, apparatus, and system for authentication using labels containing nuleotide sequences US patent application: US 2006\/0286569 A1."},{"key":"10.1016\/j.ijpharm.2019.118656_b0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/d8010002","article-title":"DNA barcoding as a molecular tool to track down mislabeling and food piracy","volume":"8","author":"Barcaccia","year":"2015","journal-title":"Diversity"},{"key":"10.1016\/j.ijpharm.2019.118656_b0030","first-page":"216","article-title":"The health and economic effects of counterfeit drugs","volume":"7","author":"Blackstone","year":"2014","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.ijpharm.2019.118656_b0035","doi-asserted-by":"crossref","first-page":"10615","DOI":"10.1021\/jf503413f","article-title":"Labeling milk along its production chain with DNA encapsulated in silica","volume":"62","author":"Bloch","year":"2014","journal-title":"J. Agric. Food Chem."},{"year":"2019","series-title":"British Pharmacopoeia 2019","author":"British Pharmacopoeia Commission","key":"10.1016\/j.ijpharm.2019.118656_b0040"},{"key":"10.1016\/j.ijpharm.2019.118656_b0045","unstructured":"Code of Federal Regulations, 2018. 21 CFR 170.30, April 1, 2018. Chapter 1 \u2013 Food and Drug administration, Department of Health and Human Services, Subchapeter B \u2013 Food for human comsumption. Food Additives. Title 21, Volume 3. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/cfrsearch.cfm?fr=170.30 (accessed 04.02.19)."},{"key":"10.1016\/j.ijpharm.2019.118656_b0050","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.optlaseng.2012.05.016","article-title":"Drug packaging security by means of white-light speckle","volume":"50","author":"Cozzella","year":"2012","journal-title":"Opt. Lasers Eng."},{"key":"10.1016\/j.ijpharm.2019.118656_b0055","first-page":"1","article-title":"Overview of pharmaceutical excipients used in tablets and capsules","volume":"24","author":"Dave","year":"2008","journal-title":"Drug Topics"},{"key":"10.1016\/j.ijpharm.2019.118656_b0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.forsciint.2018.08.023","article-title":"Packaging analysis of counterfeit medicines","volume":"291","author":"D\u00e9gardin","year":"2018","journal-title":"Forens. Sci. Int."},{"key":"10.1016\/j.ijpharm.2019.118656_b0065","unstructured":"FDA Federal Register, 1992. Statement of Policy \u2013 Foods Derived from New Plant Varieties. Volume 57-1992 https:\/\/www.fda.gov\/food\/guidanceregulation\/guidancedocumentsregulatoryinformation\/biotechnology\/ucm096095.htm (accessed 04.02.19)."},{"key":"10.1016\/j.ijpharm.2019.118656_b0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.trac.2006.06.003","article-title":"Thin-layer chromatography in testing the purity of pharmaceuticals","volume":"25","author":"Ferenczi-Fodor","year":"2006","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.ijpharm.2019.118656_b0075","series-title":"Current Protocols Essential Laboratory Techniques","first-page":"10.3.1","article-title":"Real-time PCR","author":"Fraga","year":"2008"},{"key":"10.1016\/j.ijpharm.2019.118656_b0080","first-page":"128","article-title":"Health risks related to illegal and on-line sale of drugs and food supplements: results of a survey on marketed products in Italy from 2011 to 2013","volume":"52","author":"Gaudiano","year":"2016","journal-title":"Annali dell'Istituto superiore di sanita"},{"key":"10.1016\/j.ijpharm.2019.118656_b0085","first-page":"11","article-title":"Counterfeit drugs and medical devices in developing countries","volume":"5","author":"Glass","year":"2014","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.ijpharm.2019.118656_b0090","first-page":"16","article-title":"A high-sensitivity, high-speed DSC technique: measurement of amorphous lactose","volume":"35","author":"Gabbott","year":"2003","journal-title":"Am. Lab."},{"key":"10.1016\/j.ijpharm.2019.118656_b0095","unstructured":"Hayward, J. A., Hogan, M. E., Liang, M. B., Jung, L., 2018. Method for authenticating active pharmaceutical ingredients: Patent Application US20180142294A1."},{"year":"2009","series-title":"British National Formulary (BNF) September 2009","author":"Joint Formulation Committee","key":"10.1016\/j.ijpharm.2019.118656_b0100"},{"key":"10.1016\/j.ijpharm.2019.118656_b0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bcp.12298","article-title":"Substandard drugs: a potential crisis for public health","volume":"78","author":"Johnston","year":"2014","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.118656_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0218314","article-title":"Rapid authentication of pharmaceuticals via DNA tagging and field detection","volume":"14","author":"Jung","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2019.118656_b0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/dna.2013.2056","article-title":"Thermal degradation of DNA","volume":"32","author":"Karni","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ijpharm.2019.118656_b0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1477370814554722","article-title":"The online trade in counterfeit pharmaceuticals: new criminal opportunities, trends and challenges","volume":"12","author":"Lavorgna","year":"2015","journal-title":"Eur. J. Criminol."},{"key":"10.1016\/j.ijpharm.2019.118656_b0125","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/362709a0","article-title":"Instability and decay of the primary structure of DNA","volume":"362","author":"Lindahl","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2019.118656_b0130","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1002\/jps.22679","article-title":"The global counterfeit drug trade: patient safety and public health risks","volume":"100","author":"Mackey","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.118656_b0135","first-page":"33","article-title":"DNA molecular taggants: a hidden key to pharmaceutical patient safety","volume":"16","author":"Murrah","year":"2010","journal-title":"Tablets Capsules"},{"key":"10.1016\/j.ijpharm.2019.118656_b0140","unstructured":"Murray E, Gregg DA, Norton ML, Swick JT, Towler WI., 2012. Method for a continuous rapid thermal cycle system. US Patent 8,163,489. Awarded April 24, 2012."},{"key":"10.1016\/j.ijpharm.2019.118656_b0145","series-title":"New Perspectives in Forensic Human Skeletal Identification","first-page":"129","article-title":"Chapter 12 \u2013 the utilization of databases for the identification of human remains A2 \u2013 Latham, Krista E","author":"Osborn-Gustavson","year":"2018"},{"key":"10.1016\/j.ijpharm.2019.118656_b0150","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1002\/anie.201208135","article-title":"Protection and deprotection of DNA\u2014high-temperature stability of nucleic acid barcodes for polymer labeling","volume":"52","author":"Paunescu","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijpharm.2019.118656_b0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.powtec.2015.12.035","article-title":"Particles with an identity: tracking and tracing in commodity products","volume":"291","author":"Paunescu","year":"2016","journal-title":"Powder Technol."},{"key":"10.1016\/j.ijpharm.2019.118656_b0160","first-page":"05","article-title":"Pharmaceutical fakes: a dangerous pandemic","volume":"15","author":"Perks","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijpharm.2019.118656_b0165","unstructured":"SelectDNA\u00ae, 2019. https:\/\/www.selectadna.co.uk (accessed 04.02.19)."},{"key":"10.1016\/j.ijpharm.2019.118656_b0170","unstructured":"Taylor, C., 2015. Marking material (pp. 1-4): US Patent: US9171443B2."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731930701X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731930701X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:39:37Z","timestamp":1759916377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731930701X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":34,"alternative-id":["S037851731930701X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118656","relation":{},"ISSN":["0378-5173"],"issn-type":[{"type":"print","value":"0378-5173"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-counterfeiting DNA molecular tagging of pharmaceutical excipients: An evaluation of lactose containing tablets","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118656"}}